Linnaeus Bioscience Inc. is dedicated to the discovery, development and commercialization of innovative technologies that accelerate drug discovery. We offer a large array of antibiotic discovery assays including MIC testing against panels of clinical isolates and mechanism of action studies. Our Bacterial Cytological Profiling (BCP) platform provides a revolutionary new approach for discovering new compounds to treat microbial disease and emerging drug resistant bacterial infections.